Pyruvate prevents the inhibition of the long-term potentiation induced by amyloid-β through protein phosphatase 2A inactivation

Journal of Alzheimer's Disease

Volumn 30, Issue 3, 2012, Pages 665-673

  Wang, Xiaonan ^a   Takata, Toshihiro ^b,c   Bai, Xiaojuan ^a,d   Ou, Fengrong ^a   Yokono, Koichi ^b   Sakurai, Takashi ^b,c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

Amyloid oligomer; calmodulin dependent protein kinase 1; long term potentiation; protein phosphatase 2A; pyruvate; reactive oxygen species

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; FOSTRIECIN; LACTATE SODIUM; PHOSPHOPROTEIN PHOSPHATASE 2A; PYRUVATE SODIUM; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHOSPHORYLATION; BRAIN SLICE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84862867033     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-101869     Document Type: Article

References (55)

1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
2. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta potently inhibit hippocampal longterm potentiation in vivo. Nature 416, 535-539.
3. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
4. Hock C, Konietzko U, Streffer JR, Tracy J, Signorell A, Muller-Tillmanns B, Lemke U, Henke K, Moritz E,Wollmer MA, Umbricht D, de Quervain DJ, Hofmann M, Maddalena A, Papassotiropoulos A, NitschRM(2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38, 547-554.
5. Klyubin I,Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, Rowan MJ (2005) Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo. Nat Med 11, 556-561.
6. Schenk DB, Seubert P, Grundman M, Black R (2005) A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease. Neurodegener Dis 2, 255-260.
7. Fukunaga K, Muller D, Miyamoto E (1995) Increased phosphorylation of Ca2+/calmodulin-dependent kinase II and its endogenous substrates in the induction of long-term potentiation. J Biol Chem 270, 6119-6124.
8. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR (1997) Regulatory phosphorylation of AMPA-type glutamate receptors by CaMK-II during long-term potentiation. Science 276, 2042-2045.
9. Sanhueza M, McIntyre CC, Lisman JE (2007) Reversal of synaptic memory by Ca2+/calmodulin-dependent kinase II inhibitor. J Neurosci 27, 5190-5199.
10. Pastalkova E, Serrano P, Pinkhasova D, Wallace E, Fenton AA, Sacktor TC (2006) Storage of spatial information by the maintenance mechanism of LTP. Science 313, 1141-1144.
11. Zhao DY, Watson JB, Xie CW (2004) Amyliod-prevent activation of calcium/calmodulin dependent protein kinase II and AMPA receptor phosphorylation during hippocample long-term potentiation. J Neurophysiol 2, 2853-2858.
12. Janssens V, Goris J (2001) Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 353, 417-439.
13. Lechward K,Awotunde OS, SwiatekW, MuszynskaG(2001) Protein phosphatase 2A: Variety of forms and diversity of functions. Acta Biochim Pol 48, 921-933.
14. Maalouf M, Rho JM (2008) Oxidative impairment of hippocampal long-term potentiation involves activation of protein phospahatase 2A and is prevented by ketone bodies. J Neurosci Res 86, 322-330.
15. Fukunaga K, Muller D, Ohmitsu M, Baḱo E, DePaoli-Roach AA, Miyamoto E (2000) Decreased protein phosphatase 2A activity in hippocampal long-term potentiation. J Neurochem 74, 807-817.
16. Matton MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639.
17. Nunomura A, Castellani DJ, Zhu X, Moreira P, Perry G, Smith MA (2006) Involvement of oxidative stress in Alzheimer's disease. J Neuropathol Exp Neurol 65, 631-641.
18. Perry G, Castellani RJ, Hirai K, Smith MA (1998) Reactive oxygen species mediate cellular damage in Alzheimer's disease. J Alzheimers Dis 1, 45-55.
19. Selkoe DJ (2000) Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of betaprotein. Ann NY Acad Sci 924, 17-25.
20. Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, Tabaton M (2005)-site APP cleaving enzyme up-regulation induced by 4-hydroxynonnenal is mediated by stress-activated protein kinases pathways. J Neurochem 92, 628-636.
21. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Massimo MP, Tabaton M (2008) Oxidative stress activates a positive feedback between the-and-secretase cleavages of the-amyloid precursor protein. J Neurochem 104, 683-695.
22. Desagher S, Glowinski J, Premont J (1997) Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci 17, 9060-9067.
23. Alvarez G, Ramos M, Ruiz F, Satŕustegui J, Boǵonez E (2003) Pyruvate protection against-amyloid-induced neuronal death: Role of mitochondrial redox state. J Neurosci Res 73, 260-269.
24. Wang XN, Takata T, Sakurai T, Yokono K (2007) Different effects of monocarboxylates on neuronal survival and-amyloid toxicity. Eur J Neurosci 26, 2142-2150.
25. Wang X, Song X, Takata T, Miichi Y, Yokono K, Sakurai T (2010) Amyloid-neurotoxicity restricts glucose window for neuronal survival in rat hippocampal slice cultures. Exp Gerontol 45, 904-908.
26. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37, 173-182.
27. Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, Morabito M, Almeida OFX (2005) Soluble-Amyloid1?40 induces NMDA-dependert degradation of postsynaptic density-95 at glutamatergic synapses. J Neurosci 25, 11061-11070.
28. Okada Y (1974) Recovery of neuronal activity and highenergy compound level after complete and prolonged brain ischemia. Brain Res 72, 346-349.
29. Makhinson M, Chotiner JK, Watson JB, O'Dell TJ (1999) Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca2+/calmodulin-dependent kinase II autophosphorylation. J Neurosci 19, 2500-2510.
30. Wang CN, Chi CW, Lin YL, Chen CF, Shiao YJ (2001) The neuroprotective effects of phytoestrogens on amyloid-protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J Biol Chem 276, 5287-5295.
31. Lewy DS, Gauss CM, Soenen DR, Boger DL (2002) Fostriecin chemistry and biology. Curr Med Chem 9, 2005-2032.
32. Chen QS, Wei WZ, Shimahara T, Xie CW (2002) Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem 77, 354-371.
33. Winder DG, Sweatt JD (2001) Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci 2, 461-474.
34. R̈onicke R, Mikhaylova M, R̈onick S, Meinhardt J, Schr̈oder UH, Fr̈andrich M, Reiser G, Kreutz MR, ReymannKG(2011) Early neuronal dysfunction by amyloid-oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol Aging 32, 2219-2228.
35. Hu NM, Klyubin I, Anwyl R, Rowan MJ (2009) GluN2B subunit-containing NMDA receptor antagonists prevent A-mediated synaptic plasticity disruption in vivo. Proc Natl Acad Sci U S A 106, 20504-20509.
36. Schworer CM, Colbran RJ, Soderling TR (1986) Reversible generation of a Ca2+-dependent from of Ca2+ (calmodulin)-dependent protein kinase II by an autophosphorylation mechanism. J Biol Chem 261, 8581-8584.
37. Strack S, Choi S, Lovinger DM, Colbran RJ (1997) Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density. J Biol Chem 272, 13467-13470.
38. Lai Y, nairn AC, Greengard P (1986) Autophosphorylation reversibly regulated the Ca2+/calmodulin-dependence of Ca2+/calmodulin-dependent protein kinase II. Proc Natl Acad Sci U S A 83, 4253-4257.
39. SaitohY,Yamamoto H, FukubagaK,MatsukadoY, Miyamoto E (1987) Inactivation and reactivation of the multifunctional calmodulin-dependent protein kinase from brain by autophosphorylation and dephosphorylation: Involvement of protein phosphatases fron brain. J Neurochem 49, 1286-1292.
40. Miller SG, Patton BL, Kennedy MB (1988) Sequences of auphosphorylation sites in neural type II CaM kinase that control Ca2+-dependent activity. Neuron 1, 593-604.
41. Fukunaga K, Kobayashi T, Tamura S, Miyamoto E (1993) Dephosphorylation of autophosphorylated Ca2+/calmodulindependent kinase II by protein phosphatase 2C. J Biol Chem 268, 133-137.
42. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith MA, Perry G, Godman GC, Nawroth P, et al. (1995) Nonenzymatically glycated tau in Alzhheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat Med 1, 693-699.
43. Tamagno E, Bardini P, Obbili A,Vitali A, Roberta B, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M (2002) Oxidative stress increase expression and activity of BACE in NT2 neurons. Neurobiol Dis 10, 279-288.
44. MottonMP(1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77, 1081-1082.
45. Behl C, Davis J, Cole GM, Shubert D (1992) Vitamin E protects nerve cells from amyliod-protein toxicity. Biochem Biophys Res Commun 186, 944-950.
46. Rottkamp CA, Raina AK, Zhu X, Gaier Elizabeth, Bush AI, Atwood CS, Chevion M, Perry G, Smith MA (2001) Redoxactive iron mediates amyliod-toxicity. Free Radic Biol Med 30, 447-450.
47. Sundaresan M, Yu Z-X, Ferrans VJ, Irani K, Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
48. Sen CK (1998) Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55, 1747-1758.
49. Morel Y, Barouki R (1999) Repression of gene expression by oxidative stress. Biochem J 342, 481-496.
50. Katsuki H, Nakanishi C, Saito H, Matsuki N (1997) Biphasic effect of hyfrogen peroxide on field potentials in rat hippocampal slices. Eur J Pharmacol 337, 213-218.
51. Frantseva MV, Velazquez JLP, Carlen PL (1998) Changes in membrane and synaptic properties of thalamocortical circuitry caused by hydrogen peroxide. J Neurophysiol 80, 1317-1326.
52. Knapp LT, Klann E (2002) Role of reactive oxygen species in hippocampal long-term potentiation: Contributory or inhibitory? J Neurosci Res 70, 1-7.
53. Serrano F, KlannE(2004) Reactive oxygen species and synaptic plasticity in the aging hippocampus. Aging Res Rev 3, 431-443.
54. Klann E, Thiel E (1999) Modulation of protein kinases and protein phosphatases by reactive oxygen species: Implication for hippocampal synaptic plasticity. Prog Neuropsychophamacol Biol Psychiatry 23, 359-376.
55. Hsu MJ, Sheu JR, Lin CH, Shen MY, Hsu CY (2010) Mitochondrial mechanisms in amyloid beta peptide-induced cerebrovascular degeneration. Biochim Biophys Acta 3, 290-296.